RankingsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Total non-current assets

RaQualia Pharma Inc.【JP:4579】

Market cap
¥22.3B
P/E ratio
-313.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current assets (Million JPY)YoY (%)
Dec 31, 20245,117+167.17%
Dec 31, 20231,915+33.40%
Dec 31, 20221,436+16.67%
Dec 31, 20211,230-13.17%
Dec 31, 20201,417-19.92%
Dec 31, 20191,769-15.34%
Dec 31, 20182,090+19.99%
Dec 31, 20171,742-21.29%
Dec 31, 20162,213+8.24%
Dec 31, 20152,044+5.33%
Dec 31, 20141,941

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)